Crossref
Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model.
Osteoarthritis and Cartilage · 2026-04 · 34 · S55
DOI: 10.1016/j.joca.2026.01.049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026-04. Verfasst von Félix Renaudin und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Renaudin, F., Zocola, E., Diabanza, C., Bouchemla, Z., Laumonier, T., & Hannouche, D. (2026). Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model. Osteoarthritis and Cartilage, 34, S55. https://doi.org/10.1016/j.joca.2026.01.049
Vancouver
Renaudin F, Zocola E, Diabanza C, Bouchemla Z, Laumonier T, Hannouche D. Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model. Osteoarthritis and Cartilage. 2026;34:S55. doi:10.1016/j.joca.2026.01.049
BibTeX
@article{Renaudin2026,
author = {Renaudin, Félix and Zocola, Elodie and Diabanza, Cynthia and Bouchemla, Zohra and Laumonier, Thomas and Hannouche, Didier},
title = {Oral administration of Setanaxib delays osteoarthritis progression in a DMM murine model},
journal = {Osteoarthritis and Cartilage},
year = {2026},
volume = {34},
pages = {S55},
doi = {10.1016/j.joca.2026.01.049}
}
EUVIMED